Medical Articles 10/2
Familial Mediterranean Fever Gene as a Possible Modifier of Sweet Syndrome with Chronic Myelogenous Leukemia.
Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors.
Pharmacokinetics of oral posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome.
Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia.
